161 related articles for article (PubMed ID: 33602765)
1. Painful, reappearing eruption in a medically complex 4-year-old.
Sooy M; Randell RL; Tchapyjnikov D; Werner K; Nazareth-Pidgeon K
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33602765
[TBL] [Abstract][Full Text] [Related]
2. Infrequent SCN9A mutations in congenital insensitivity to pain and erythromelalgia.
Klein CJ; Wu Y; Kilfoyle DH; Sandroni P; Davis MD; Gavrilova RH; Low PA; Dyck PJ
J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):386-91. PubMed ID: 23129781
[TBL] [Abstract][Full Text] [Related]
3. An atypical case of SCN9A mutation presenting with global motor delay and a severe pain disorder.
Meijer IA; Vanasse M; Nizard S; Robitaille Y; Rossignol E
Muscle Nerve; 2014 Jan; 49(1):134-8. PubMed ID: 23893323
[TBL] [Abstract][Full Text] [Related]
4. Gain-of-function mutation of a voltage-gated sodium channel Na
Tanaka BS; Nguyen PT; Zhou EY; Yang Y; Yarov-Yarovoy V; Dib-Hajj SD; Waxman SG
J Biol Chem; 2017 Jun; 292(22):9262-9272. PubMed ID: 28381558
[TBL] [Abstract][Full Text] [Related]
5. A severe case of primary erythromelalgia presenting as small fiber neuropathy with a novel SCN9A mutation.
Watabe D; Tominaga M; Toyama S; Takamori K; Nakano H; Amano H
J Dermatol; 2023 Jul; 50(7):938-941. PubMed ID: 36815391
[TBL] [Abstract][Full Text] [Related]
6. Primary erythromelalgia in a 12-year-old boy: positive response to sodium channel blockers despite negative SCN9A mutations.
Jakob A; Creutzfeldt R; Staszewski O; Winterpacht A; Berner R; Hufnagel M
Klin Padiatr; 2012 Sep; 224(5):309-12. PubMed ID: 22170168
[TBL] [Abstract][Full Text] [Related]
7. Mutation in Na
Haehner A; Hummel T; Heinritz W; Krueger S; Meinhardt M; Whitcroft KL; Sabatowski R; Gossrau G
Eur J Pain; 2018 Nov; 22(10):1767-1773. PubMed ID: 29934995
[TBL] [Abstract][Full Text] [Related]
8. A Novel SCN9A Mutation (F826Y) in Primary Erythromelalgia Alters the Excitability of Nav1.7.
Wu B; Zhang Y; Tang H; Yang M; Long H; Shi G; Tang J; Shi X
Curr Mol Med; 2017; 17(6):450-457. PubMed ID: 28990532
[TBL] [Abstract][Full Text] [Related]
9. Bilateral congenital corneal anesthesia in a patient with SCN9A mutation, confirmed primary erythromelalgia, and paroxysmal extreme pain disorder.
Kim DT; Rossignol E; Najem K; Ospina LH
J AAPOS; 2015 Oct; 19(5):478-9. PubMed ID: 26486037
[TBL] [Abstract][Full Text] [Related]
10. Nav1.7-A1632G Mutation from a Family with Inherited Erythromelalgia: Enhanced Firing of Dorsal Root Ganglia Neurons Evoked by Thermal Stimuli.
Yang Y; Huang J; Mis MA; Estacion M; Macala L; Shah P; Schulman BR; Horton DB; Dib-Hajj SD; Waxman SG
J Neurosci; 2016 Jul; 36(28):7511-22. PubMed ID: 27413160
[TBL] [Abstract][Full Text] [Related]
11. Pediatric Erythromelalgia and SCN9A Mutations: Systematic Review and Single-Center Case Series.
Arthur L; Keen K; Verriotis M; Peters J; Kelly A; Howard RF; Dib-Hajj SD; Waxman SG; Walker SM
J Pediatr; 2019 Mar; 206():217-224.e9. PubMed ID: 30416015
[TBL] [Abstract][Full Text] [Related]
12. Secondary erythromelalgia successfully treated with intravenous immunoglobulin.
Moody S; Pacheco S; Butler IJ; Koenig MK
J Child Neurol; 2012 Jul; 27(7):922-3. PubMed ID: 22156790
[TBL] [Abstract][Full Text] [Related]
13. Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.
Natkunarajah J; Atherton D; Elmslie F; Mansour S; Mortimer P
Clin Exp Dermatol; 2009 Dec; 34(8):e640-2. PubMed ID: 19549232
[TBL] [Abstract][Full Text] [Related]
14. Novel SCN9A mutations underlying extreme pain phenotypes: unexpected electrophysiological and clinical phenotype correlations.
Emery EC; Habib AM; Cox JJ; Nicholas AK; Gribble FM; Woods CG; Reimann F
J Neurosci; 2015 May; 35(20):7674-81. PubMed ID: 25995458
[TBL] [Abstract][Full Text] [Related]
15. A Case of Pediatric Auricular Erythromelalgia.
Reese A; DiNardo L; Powers K; Carr MM
Cureus; 2022 Jan; 14(1):e21088. PubMed ID: 35155035
[TBL] [Abstract][Full Text] [Related]
16. Topical treatments for erythromelalgia.
Raef HS; Williams M; Fedeles F
Dermatol Ther; 2022 Nov; 35(11):e15860. PubMed ID: 36164837
[TBL] [Abstract][Full Text] [Related]
17. Autonomic dysfunction in SCN9A-associated primary erythromelalgia.
Kim MK; Yuk JW; Kim HS; Park KJ; Kim DS
Clin Auton Res; 2013 Apr; 23(2):105-7. PubMed ID: 23152140
[TBL] [Abstract][Full Text] [Related]
18. Primary erythromelalgia: a review.
Tang Z; Chen Z; Tang B; Jiang H
Orphanet J Rare Dis; 2015 Sep; 10():127. PubMed ID: 26419464
[TBL] [Abstract][Full Text] [Related]
19. Novel mutations mapping to the fourth sodium channel domain of Nav1.7 result in variable clinical manifestations of primary erythromelalgia.
Cregg R; Laguda B; Werdehausen R; Cox JJ; Linley JE; Ramirez JD; Bodi I; Markiewicz M; Howell KJ; Chen YC; Agnew K; Houlden H; Lunn MP; Bennett DL; Wood JN; Kinali M
Neuromolecular Med; 2013 Jun; 15(2):265-78. PubMed ID: 23292638
[TBL] [Abstract][Full Text] [Related]
20. Life-threatening hypothermia in a child with primary erythromelalgia.
Matarneh B; Witman P
Pediatr Dermatol; 2022 Jan; 39(1):135-136. PubMed ID: 34888934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]